deltatrials
Completed PHASE3 INTERVENTIONAL 4-arm NCT02980133

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Conditions Asthma
Interventions Fluticasone Propionate Fluticasone Propionate/Salmeterol Placebo MDPI
Updated 28 times since 2017 Last updated: Nov 5, 2021 Started: Dec 28, 2016 Primary completion: Apr 7, 2019 Completion: Apr 13, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02980133, this PHASE3 trial focuses on Asthma and remains completed. Sponsored by Teva Branded Pharmaceutical Products R&D, Inc., it has been updated 28 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~May 2017 · 30 days · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Nov 2017 · 3 months · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~May 2018 · 2 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Apr 2020 · 7 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

28 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

▶ Show 23 earlier versions

  1. May 2020 — Jan 2021 [monthly]

    Completed PHASE3

  2. Apr 2020 — May 2020 [monthly]

    Completed PHASE3

  3. Sep 2019 — Apr 2020 [monthly]

    Completed PHASE3

  4. Aug 2019 — Sep 2019 [monthly]

    Completed PHASE3

  5. Jul 2019 — Aug 2019 [monthly]

    Completed PHASE3

  6. Jun 2019 — Jul 2019 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  7. Mar 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

  8. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

  9. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE3

  10. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE3

  11. Aug 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  12. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  13. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  14. Mar 2018 — May 2018 [monthly]

    Recruiting PHASE3

  15. Jan 2018 — Mar 2018 [monthly]

    Recruiting PHASE3

  16. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE3

  17. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE3

  18. Aug 2017 — Nov 2017 [monthly]

    Recruiting PHASE3

  19. Jun 2017 — Aug 2017 [monthly]

    Recruiting PHASE3

  20. May 2017 — Jun 2017 [monthly]

    Recruiting PHASE3

  21. Apr 2017 — May 2017 [monthly]

    Recruiting PHASE3

  22. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  23. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Teva Branded Pharmaceutical Products R&D, Inc.
Data source: Teva Branded Pharmaceutical Products R&D, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bakersfield, United States , Baytown, United States , Bellingham, United States , Birmingham, United States , Boerne, United States , Budapest, Hungary , Canton, United States , Centennial, United States , Charleston, United States , Charlotte, United States and 77 more locations